About Hexagon Nutrition

Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.

The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.

Its product portfolio is classified into three segments:

Branded wellness and clinical nutrition products (B2C)
Premix formulations (B2B2C)
Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) under ESG initiatives

Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence.

The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025.

Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.

Financials of Hexagon Nutrition

Total Assets

Revenue

Profit after Tax

*All values are in Rs. Cr

Category	Shares Offered	Shares Applied
QIBs Investor	0.00	0.00
Total HNIs Investor	0.00	0.00
Retail Investor	0.00	0.00
Shareholders Investor	0.00	0.00
Employee Investor	0.00	0.00
Total Subscription	--	--

Updated on N/A

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Profit*	Last Updated

Strengths of Company

One of India's leading customized micronutrient premix manufacturers.
Strong research and development capabilities with focus on innovation.
Diversified portfolio across wellness, clinical nutrition, premixes, and therapeutic nutrition.
Exports to more than 75 countries.
Established manufacturing facilities in India and Uzbekistan with quality certifications.
Strong customer relationships and pan-India distribution network.

Risks of Company

Heavy dependence on the premix formulation business for revenue.
Revenue concentration among a limited number of customers.
Raw material price volatility and dependence on imported ingredients.
Competition from domestic and multinational nutrition companies.
IPO is a pure OFS, so no fresh capital comes into the company.
Capacity utilization has remained relatively low in some segments

IPO Lead Manager(s)

Cumulative Capital Private Limited

Registration No. : 414974

Lead Manager Details

Cumulative Capital Private Limited

Contact Person: Kaushik Gandhi / Prince Jaiswal
SEBI Registration Number: 414974
Investor Grievance Email: compliance@catalystcapital.in
Website: https://www.cumulativecapital.group/home
Email: mb@catalystcapital.in
Phone: --

Hexagon Nutrition FAQs

The Hexagon Nutrition IPO is a MAIN IPO with a total issue size of ₹ 139 crores. The IPO price band is fixed at ₹42 to ₹45 per share, and the minimum lot size is 333 Shares. The Hexagon Nutrition IPO will open on 5th Jun 2026, and will close on 9th Jun 2026. Kfin Technologies Ltd. has been appointed as the registrar for the issue. The equity shares are proposed to be listed on BSE,NSE.

The Hexagon Nutrition IPO opens on 5th Jun 2026 and closes on 9th Jun 2026.

The Hexagon Nutrition IPO lot size is 333 Share, and the minimum amount required for application is ₹ 14,985.

You can apply for the Hexagon Nutrition IPO through your bank account using the ASBA facility or via your online trading and Demat account. To apply online, log in to your broker’s platform, select Hexagon Nutrition IPO, enter the number of lots, choose your price within the price band, and submit the application. After submitting, approve the UPI mandate to block the required amount in your bank account. Once the IPO allotment is finalised, shares will be credited to your Demat account if allotted. If not allotted, the blocked amount will be released automatically.

The Hexagon Nutrition IPO listing date is 12th Jun 2026.